Sumitomo Pharma Market Cap

Sumitomo Pharma has a market cap or net worth of 729.03 billion as of March 13, 2026. Its market cap has increased by 127.38% in one year.

Market Cap

729.03B

Enterprise Value

930.66B

Revenue

453.40B

Ranking

n/a

PE Ratio

6.62

Stock Price

1,835.00

Market Cap Chart

Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 729.03B, an increase of 254.02%. That is a compound annual growth rate of 3.77%.

Market Cap History

Date	Market Cap	% Change
Mar 13, 2026	729.03B	-20.84%
Dec 30, 2025	920.92B	311.72%
Dec 30, 2024	223.67B	20.82%
Dec 29, 2023	185.14B	-53.35%
Dec 30, 2022	396.90B	-24.60%
Dec 30, 2021	526.41B	-13.00%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shionogi &	2.90T
Eisai	1.36T
Hisamitsu Pharmaceutical Co.	423.03B
Nippon Shinyaku	368.82B
Toho Holdings	294.39B
Tsumura & Co.	285.95B
Sawai Group Holdings	245.64B
Towa Pharmaceutical	202.33B

Market Cap Rankings